BOD Science Sells Key IP Assets in Strategic Move Amid DOCA

• Sale of three intellectual property rights including Aqua Phase and CLIC Protein IP
• Consideration includes AU$125,000 cash, £2 million debt forgiveness, and 5% equity in Optimus Salvus
• Proceeds to fund creditors via the Creditors' Trust under the DOCA
• Transaction finalised after extensive negotiations with Optimus Salvus and Aqua Phase inventors